1 completed, 1 not yet recruiting, 1 unknown. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Not yet recruiting 1, Unknown 1 |
Follow Neuroinflammatory Response: new trials by email Literature Review of Neuroinflammatory Response trials Research Report on Neuroinflammatory Response
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Minocycline In Neurocognitive Outcomes - Sickle Cell Disease Minocycline, Placebo - Sickle Cell Disease, Cognitive Impairment | Phase 1 | Not yet recruiting | University of Cincinnati | 30 | 2026-12-01 | 2026-11-03 |
| Safety & PK of Single Doses of MT1980 MT1980, Placebo - Neuroinflammatory Response | Phase 1 | Completed | Monument Therapeutics Limited | 24 | 2022-06-01 | 2022-11-02 |
| Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831 Drug: NA-831 - 0.10 mg/kg, Placebo- 0.10 mg/kg, Drug: NA-831 - 0.20 mg/kg - Covid19, Corona Virus Infection | Phase 1 | Unknown | Biomed Industries, Inc. | 45 | 2020-09-15 | 2020-07-21 |
Neuroinflammatory Diseases (3) · Cognitive Dysfunction (2) · Anemia, Sickle Cell (1) · COVID-19 (1) · Cognition Disorders (1) · Coronavirus Infections (1) · Nerve Degeneration (1) · Pneumonia (1) · Severe Acute Respiratory Syndrome (1)
Inflammation (3) · Nervous System Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Mental Disorders (2) · Neurocognitive Disorders (2) · Anemia (1) · Anemia, Hemolytic (1) · Anemia, Hemolytic, Congenital (1) · Cognition Disorders (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Coronaviridae Infections (1) · Genetic Diseases, Inborn (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1)
Minocycline (1) · remdesivir (1)
Biomed Industries, Inc. (1) · Monument Therapeutics Limited (1) · University of Cincinnati (1)
Netherlands (1) · United States (1)
Lloyd Tran, PhD (1)